FdaApplication

NDA 206488

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSAREPTA THERAPEUTICS INC
application_typeNDA
approval_date2016-09-19

Products (2)

ProductActive ingredientStrengthDosage form
EXONDYS 51ETEPLIRSEN100MG/2ML (50MG/ML)SOLUTION;INTRAVENOUS
EXONDYS 51ETEPLIRSEN500MG/10ML (50MG/ML)SOLUTION;INTRAVENOUS

2 products